Nicorette Spearmint Burstnicotine polacrilex

According to the FDA label: Use reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking

19,163 adverse event reports submitted to the FDA (2004–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Nicorette Spearmint Burst in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Nicorette Spearmint Burst adverse event reports by reporter sex
SexReports
Female8,889
Male6,264
Unknown61

By Age Group

View age group data as a table
Nicorette Spearmint Burst adverse event reports by reporter age group
Age groupReports
0-1797
18-341,033
35-492,202
50-643,193
65-741,628
75+508

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Nicorette Spearmint Burst. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Nicorette Spearmint Burst adverse event reports by reported outcome
OutcomeReports
Non-Serious15,382
Other Serious3,159
Hospitalization890
Death147
Life-Threatening104
Disability96

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Nicorette Spearmint Burst. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Nicorette Spearmint Burst adverse event reports by year
YearReports
2004113
2005188
2006726
20071,058
2008881
2009940
2010947
20111,180
20121,319
20131,064
2014218
20151,302
20161,236
20171,253
20181,077
2019949
2020888
20211,035
2022782
2023664
2024519
2025608
2026 (partial)216

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Nicorette Spearmint Burst

In FDA adverse event reports that mention Nicorette Spearmint Burst, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026